PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 16225157

Diabetes and tuberculosis interface.

Samar Banerjee·Mandira Banerjee
View original source ↗Export metadata ↓

Abstract

Diabetes mellitus is often complicated by acute or chronic infections, as it is a secondary immune deficiency disorder. Diabetes mellitus produces immune alterations of both cellular and humoral immunity. Tuberculosis in diabetes mellitus is 2-5 times higher. Chances of recurrence with multidrug resistant bacteria are common. More cavitary lesions, less sputum positivity and with relative paucity of symptoms and signs are the features. Treatment for diabetes mellitus should be done with insulin. Every diabetic person should be screened for tuberculosis and every tuberculosis patient should also be searched for diabetes.

Explore related subjects

ComorbidityDiabetes MellitusHumansTuberculosisJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Samar Banerjee, Mandira Banerjee. 2005. Diabetes and tuberculosis interface.. https://pubmed.ncbi.nlm.nih.gov/16225157/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Assessing the comorbidity between asthma and depression through polygenic risk scoring and time-to-event models.

BACKGROUND: Patients with asthma have an increased risk of developing depression, affecting their quality of life. To date, the processes contributing to this comorbidity remain unclear. METHODS: We integrated two large genome-wide association studies (88,486 patients with asthma and 447,859 controls; 412,024 patients with depression and 1,587,577 controls) with cross-sectional and longitudinal information available from the All of Us Research Program (N = 87,167) through polygenic risk scoring (PRS), Cox proportional-hazards models, one-sample Mendelian randomization (MR), and gene-set and drug-repurposing analyses. RESULTS: We observed that depression PRS was associated with increased asthma risk (hazard ratio, HR = 1.13, 95% CI = 1.09-1.17), also when accounting for comorbidity status (HR = 1.08, 95% CI = 1.04-1.12). Conversely, the effect of asthma PRS was null after accounting for comorbidity status. One-sample MR analysis showed an effect of depression genetic liability on asthma, ranging from beta = 0.36 ± 0.03 when considering a linear relationship to beta = 3.21 ± 0.31 when considering possible nonlinear relationships. Conversely, the effect of asthma genetic risk on depression was null after accounting for potential confounders. The gene-set analyses showed that asthma and depression polygenic risks share biological processes, molecular functions, and cellular components related to the immune system and the lung-brain axis. CONCLUSIONS: Genetic predisposition contributes to asthma-depression comorbidity through direct effects and shared pathogenic processes. These findings highlight the potential to develop targeted interventions to prevent and treat the co-occurrence of respiratory and neuropsychiatric disorders.

Comorbidity↗